Pharma Focus Europe

LATEST NEWSRead more...

22

Jul 2024

Apollo Therapeutics Partners with the University of Oxford to Enhance Drug Discovery and Development

The University of Oxford and Apollo Therapeutics have launched a new partnership focused on drug discovery and development aiming to translate Oxfords cuttingedge biomedical research

19

Jul 2024

Meitheal Pharmaceuticals Expands Its Specialty Biopharma Range by Acquiring CONTEPO™ (Fosfomycin for Injection) from Nabriva Therapeutics

Meitheal Pharmaceuticals Inc a biopharmaceutical company based in Chicago with a focus on generic injectables fertility treatments biologics and branded products has announced its acquisition

19

Jul 2024

NMDP BioTherapies and the Cord Blood Bank Alliance Announce Enhanced Selection of Cord Blood Units for NK and Other Cell Therapies

NMDP BioTherapiesSM and the NMDP BioTherapies Cord Blood Bank Alliance which includes nine public cord blood banks are now providing preidentified cord blood units

18

Jul 2024

Draupnir Bio Raises €12 Million in Seed Funding to Further Develop Oral Small Molecule Degraders Targeting Extracellular Proteins

Draupnir Bio a biotechnology company has raised million in equity investments to advance its innovative approach in targeted protein degradation The company focuses on developing oral

18

Jul 2024

Grünenthal Increases Investment in Latin America Production Facilities to Ensure Reliable Medicine Supply

Grnenthal a leading pharmaceutical company specializing in pain research and management has recently announced significant investments in its Latin American production sites These investments

17

Jul 2024

Genomics plc and Vertex Pharmaceuticals Extend and Expand Collaboration in Drug Discovery

Genomics plc has announced a further threeyear extension of its collaboration with Vertex Pharmaceuticals Incorporated to advance the discovery and development of precision medicines

press releasesRead more...

STADA and Alvotech launch Uzpruvo, the first approved ustekinumab biosimilar to Stelara, across Europe

STADA and Alvotech have launched Uzpruvo the first approved biosimilar to Stelara in Europe across a majority of European countries This includes the largest markets in the region where pricing and reimbursement approvals

Patient Enrollment Commenced in Pivotal Phase 3 Trial of Rexlemestrocel-L for Chronic Low Back Pain

Mesoblast Limited global leader in allogeneic cellular medicines for inflammatory diseases announced today that the confirmatory Phase trial of its allogeneic immunoselected and industrially manufactured stromal cell product

Bristol Myers Squibb Receives European Medicines Agency Validation of Application for Opdivo (nivolumab) plus Yervoy (ipilimumab) for First-Line Treatment of Unresectable

Bristol Myers Squibb today announced that the European Medicines Agency validated its Type II variation application for Opdivo plus Yervoy as a potential

Synaptogenix Announces New Collaboration with LSU Health New Orleans for Study of Proprietary Analogs in Spinal Cord Injury

Synaptogenix Inc an emerging biopharmaceutical company developing therapeutics for neurodegenerative disorders today announced a new

29 - 31

Jul 2024

16 - 17

Aug 2024

iPharma Expo 2024

Boston, USA

21 - 22

Aug 2024

22 - 24

Aug 2024

22 - 24

Aug 2024

29 - 31

Aug 2024
Thermo Fisher Scientific - mRNA Services
World Orphan Drug Congress 2024
World Vaccine Congress Europe 2024
Advanced Therapies USA 2024
cytiva

TOP ARTICLES

  • 1

    The Impact of Digital Health Technologies on Patient Outcomes

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 2

    How Drug Patents Shape the Competitive Landscape in Pharma?

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 3

    Pharmaceutical Marketing in the Digital Age: Strategies and Challenges

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 4

    The Role of Technology in Enhancing Patient Acceptance and Satisfaction

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 5

    Innovative Solutions: Cell and Gene Therapy's Impact on Pharma

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

KNOWLEDGE BANK

EDITORIAL SECTION